| Catheter ablation for atrial fibrillation with heart failure NF Marrouche, J Brachmann, D Andresen, J Siebels, L Boersma, ... New England Journal of Medicine 378 (5), 417-427, 2018 | 1892 | 2018 |
| An entirely subcutaneous implantable cardioverter–defibrillator GH Bardy, WM Smith, MA Hood, IG Crozier, IC Melton, L Jordaens, ... New England Journal of Medicine 363 (1), 36-44, 2010 | 786 | 2010 |
| Atrial fibrillation: current knowledge and recommendations for management S Levy, G Breithardt, RWF Campbell, AJ Camm, JC Daubert, M Allessie, ... European heart journal 19 (9), 1294-1320, 1998 | 574 | 1998 |
| Atrioverter: an implantable device for the treatment of atrial fibrillation HJJ Wellens, CP Lau, B Lüderitz, M Akhtar, AL Waldo, AJ Camm, ... Circulation 98 (16), 1651-1656, 1998 | 353 | 1998 |
| Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome Y Van Belle, P Janse, MJ Rivero-Ayerza, AS Thornton, ER Jessurun, ... European heart journal 28 (18), 2231-2237, 2007 | 346 | 2007 |
| Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable … PJ Schwartz, C Spazzolini, SG Priori, L Crotti, A Vicentini, M Landolina, ... Circulation 122 (13), 1272-1282, 2010 | 322 | 2010 |
| Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials M Rivero-Ayerza, DAMJ Theuns, HM Garcia-Garcia, E Boersma, ... European heart journal 27 (22), 2682-2688, 2006 | 294 | 2006 |
| Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners SS Pedersen, RT van Domburg, DAMJ Theuns, L Jordaens, RAM Erdman Psychosomatic medicine 66 (5), 714-719, 2004 | 293 | 2004 |
| The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial P Lechat, KW Brunhuber, R Hofmann, P Kuhn, HJ Nesser, J Slany, ... Lancet 353 (9146), 9-13, 1999 | 259 | 1999 |
| Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting C Dimmer, R Tavernier, N Gjorgov, G Van Nooten, DL Clement, ... The American journal of cardiology 82 (1), 22-25, 1998 | 255 | 1998 |
| The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm … E Arbelo, J Brugada, G Hindricks, AP Maggioni, L Tavazzi, P Vardas, ... European heart journal 35 (22), 1466-1478, 2014 | 252* | 2014 |
| The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort LRA Olde Nordkamp, L Dabiri Abkenari, LVA Boersma, AH Maass, ... Journal of the American College of Cardiology 60 (19), 1933-1939, 2012 | 234 | 2012 |
| Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right … MGPJ Cox, PA van der Zwaag, C van der Werf, JJ van der Smagt, ... Circulation 123 (23), 2690-2700, 2011 | 229 | 2011 |
| Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation S Lévy, P Ricard, CP Lau, NS Lok, AJ Camm, FD Murgatroyd, ... Journal of the American College of Cardiology 29 (4), 750-755, 1997 | 229 | 1997 |
| Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo L Jordaens, J Trouerbach, P Calle, R Tavernier, E Derycke, P Vertongen, ... European heart journal 18 (4), 643-648, 1997 | 221 | 1997 |
| Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a … DAMJ Theuns, T Smith, MGM Hunink, GH Bardy, L Jordaens Europace 12 (11), 1564-1570, 2010 | 220 | 2010 |
| Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts TH Mäkikallio, J Koistinen, L Jordaens, MP Tulppo, N Wood, B Golosarsky, ... The American journal of cardiology 83 (6), 880-884, 1999 | 217 | 1999 |
| Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks SS Pedersen, RT van Domburg, DAMJ Theuns, L Jordaens, RAM Erdman American heart journal 149 (4), 664-669, 2005 | 198 | 2005 |
| Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis AFL Schinkel, PA Vriesendorp, EJG Sijbrands, LJLM Jordaens, ... Circulation: Heart Failure 5 (5), 552-559, 2012 | 191 | 2012 |
| Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy LRAO Nordkamp, RE Knops, GH Bardy, Y Blaauw, LVA Boersma, JS Bos, ... American heart journal 163 (5), 753-760. e2, 2012 | 181 | 2012 |
Dominic A.M.J. TheunsCardiology, Erasmus MC, Rotterdam, the Netherlands在 erasmusmc.nl 的电子邮件经过验证
